METABOLIC MARKERS FOR DIAGNOSING OF CANCER Universiteit Hasselt
The present invention relates to a panel of metabolites in a body fluid sample that can be used for the diagnosis of breast, lung, colon and prostate cancer. More specifically, the invention relates to the NMR analysis of a urine or blood sample, whereby the simultaneous determination of the concentration of a panel of metabolites allows the diagnosis of breast, lung, colon or prostate cancer with a high sensitivity and specificity. In particular, the panel of metabolites comprises methyl histidine and proline.